Can the increase of bone mineral density following bisphosphonates treatments be explained by biomechanical considerations?
D019386:Alendronate / Q000008:administration & dosage*; D001696:Biomechanical Phenomena; D015519:Bone Density / Q000187:drug effects* / Q000502:physiology; D016723:Bone Remodeling / Q000187:drug effects* / Q000502:physiology*; D017326:Clinical Trials, Phase III as Topic; D004164:Diphosphonates / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D012680:Sensitivity and Specificity
D004164:Diphosphonates; D019386:Alendronate